Plus Therapeutics, Inc. (PSTV) Financials

PSTV Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 19.9 million 8.0 million
Dec. 31, 2025 16.3 million 12.3 million
Sept. 30, 2025 18.7 million 13.6 million
June 30, 2025 10.4 million 7.3 million

PSTV Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -7.1 million 1.0 million
Dec. 31, 2025 -6.3 million 713000
Sept. 30, 2025 -2.6 million 527000
June 30, 2025 -5.8 million 152000

PSTV Net Income

No data available :(

PSTV Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 3.0 million - -
Dec. 31, 2025 8.8 million 15000 71000
Sept. 30, 2025 16.6 million - 21000
June 30, 2025 6.9 million - 30000

PSTV Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 6.6 million
Dec. 31, 2025 3.1 million
Sept. 30, 2025 1.1 billion
June 30, 2025 209.2 million

PSTV Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 818000 2.9 million 5.3 million -
Dec. 31, 2025 30000 2.9 million 4.2 million -
Sept. 30, 2025 27000 2.4 million 3.4 million -
June 30, 2025 7000 1.2 million 1.7 million -

PSTV Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.0 million 109000
Dec. 31, 2025 1.4 million 92000
Sept. 30, 2025 1.4 million 86000
June 30, 2025 1.4 million 86000

PSTV Revenue by Segment

Graph available only for paid members. Upgrade to see it.

PSTV

Price: $5.42

52 week price:
2.90
23.50

Payout Ratio Range:
-2718.61%
0.07%

Earnings Per Share: 21.45 USD

P/E Ratio: 0.30

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 204800

Market Capitalization: 44.1 million

Links: